North America is anticipated to hold a significant share of the humanized mice model market, supported by advanced life science research infrastructure, increasing R&D investments, and growing adoption of advanced disease models. The region’s focus on accelerating drug development and improving research outcomes is expected to drive market growth through 2034. The global humanized...